Drug Trial Radar · NCT04178447
Pharmacokinetic Profile of Glepaglutide After a Single Injection in Subjects With Varying Degrees of Renal Function
Last checked: Nov 20, 2026Latest source record: Nov 18, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
16
Actual
Start
Dec 10, 2019
Primary completion
Jul 14, 2020
Study completion Jul 14, 2020
Sponsor
- Lead sponsor
- Zealand PharmaIndustry
- Sponsor type
- Industry
- First posted
- Nov 26, 2019
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Other
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is two stage design, open-label, multi-center, non-randomized trial evaluating the PK of a single, subcutaneous dose of 10 mg glepaglutide in subjects with varying degrees of renal function. The renal function will be calculated by the estimated glomerular filtration rate (eGFR) according to the Modification of Diet in Renal Disease (MDRD) equation.
Conditions
- Renal Impairment
Interventions
GlepaglutideDrug
Single dose of Glepaglutide 10 mg
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pharmacokinetic VariablesTime frame: 11 days
Locations
3 sites in 2 countries. Site status is shown where the registry gives one.
Fázis I-es Klinikai Farmakológiai
Budapest, Hungary
Szent Imre Egyetemi Oktatókórház
Budapest, Hungary
Specjalistyczne Centrum Medyczne - Prywatny Szpital
Krakow, Poland
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.